Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to the visually impaired who are using a screen reader; Press Control-F10 to open an accessibility menu.

Open accessibility options menu
  • 24/7
  • Buzz
  • Startups
  • VC
  • Finance@
  • Work@
  • Innovation
  • Opinions
  • Search
  • cleanSearch
  • Accesabillty
  • calcalist logo
bycalcalist logo
  • Homepage
  • Tags search
  • Pluristem

CTech 24/7

  • Galaxy Z Fold 7 review: The foldable that finally feels like a flagship
  • Forget B2C. The future is B2A
  • Elephant CEO on Israel’s AI future: Excelling in defense, but missing the LLM wave
  • The $250 million ARR club: Israel’s most lucrative tech startups
More stories in CTech

Pluristem

4 stories about Pluristem
  • מדענים מתקן של פלורינובה

    Tnuva building industrial cultured meat manufacturing facility

    02.03.23|Shani AshkenaziIsraeli company Plurinuva, which is rebranding under the name Ever After Foods and is owned by Tnuva and Pluristem, is building the plant that is meant to lead to lower production prices, one of the main barriers currently holding back the industry

  • Photo: Remi Zerenger and Eran Yoffi Cohen

    Tnuva doubles down on protein substitutes ahead of IPO

    12.01.22|Nurit KadoshThe food manufacturer understands that in order to stay relevant it needs to increase its investment in cultured food products

  • Yaky Yanay, CEO and President of Pluristem. Photo: David Garb

    Israeli-based Pluristem and Abu Dhabi Stem Cells Center sign deal to collaborate in development of cell therapies

    17.08.20|CTechAgreement comes just days after Israel and the United Arab Emirates (UAE) announce intention to fully normalize diplomatic relations

  • Israel Innovation Authority CEO, Ahron Ahron. Photo: Orel Cohen

    European Investment Bank, Israel Innovation Authority Collaborate on Medical Investments

    30.04.20|Elham Nasser EddinAs part of the collaboration, European Investment Bank has provided Pluristem GmbH, the German subsidiary of Israel-based medical company Pluristem, with a debt loan of €50 million (approximately $54 million)

Load more
Ctech Logo
Twitter
Twitter
Facebook
Facebook
NewsLetter
Newsletter
Contact Us
Contact Us
Rss
Rss
About CTech Terms of Use Privacy Policy
Developed by YIT UI & UX by Basch_Interactive